Dr. Wang’s research centers on functional genomics of liver cancer using genome-scale technologies paired with several national/international collaborative initiatives and clinical studies. As Head of the Liver Carcinogenesis Section, Dr. Wang oversees a basic/translational research program emphasizing new molecular approaches to define tumor subtypes and identify biomarkers for early detection, diagnosis, prognosis and prediction, to delineate the molecular mechanisms of liver cancer with applications towards precision medicine.